BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv7.33.0//EN
X-ORIGINAL-URL:https://www.cac2.org/
X-WR-CALNAME:CAC2
X-WR-CALDESC:Coalition Against Childhood Cancer
X-WR-TIMEZONE:America/New_York
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T030000
RRULE:FREQ=YEARLY;BYMONTH=03;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T010000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-8b16ef0e8dc41ac2f4d58e0a45621922@cac2.org
DTSTART;TZID=America/New_York:20260423T080000
DTEND;TZID=America/New_York:20261130T180000
DTSTAMP:20260325T151536Z
CREATED:20260325
LAST-MODIFIED:20260506
PRIORITY:5
SEQUENCE:3
TRANSP:OPAQUE
SUMMARY:2026 CureSearch PEDS
DESCRIPTION:The 2026 CureSearch PEDS meeting will be taking a different format this year. We’ve thoughtfully reimagined the format into a dynamic, four-part webinar series designed to foster deeper, more strategic dialogue across research, regulatory, clinical, and industry leaders. Most notably, the series will now be free and open to the public, which will significantly expand reach and engagement across the pediatric oncology community.\n\nThis refreshed format creates meaningful visibility and thought-leadership alignment while bringing the larger community into the conversation around pediatric cancer drug development.\n\nYou can easily register for FREE at our website here: https://curesearch.org/peds/. \n\n \nApril | The Starting Point\nApril 23 | 12:00 PM ET\nSpeakers: Beth Fox, MD – Senior Vice President, Clinical Trials Research, St. Jude; Nicole Drezner, MD – Deputy Director, Division of Oncology 2, FDA; Michael Cox, PharmD – Senior Vice President, Head of Early Development, Circle Pharma\n\nJune | Capital, Risk, and Strategy: Rethinking How Pediatric Cancer Drug Development is Funded to Move Therapies Forward\nJune 16 | 12:00-1:30pm ET\n\nSpeakers: Michele Cleary, PhD, Chief Executive Officer, Advancium Health Network; Andrew Lo, PhD, Charles E. and Susan T. Harris Professor, MIT Sloan School of Management; Wendy Jacquemet-Ross, PhD, CLP, Head of Partnerships, Childhood Cancer, LifeArc; Stacey Adam, PhD, Vice President, Science Partnerships, Foundation for the National Institutes of Health (FNIH)\n \n\nSeptember | From Lab to Clinic: Turning Pediatric Cancer Research into Real Treatments for Children\nSeptember 21 | 12:30-2:00pm ET \nSpeakers: Crystal Mackall, MD, Ernest and Amelia Gallo Family Professor and Professor of Pediatrics and Medicine, Stanford University; Ranjit S. Bindra, MD, PhD, Harvey and Kate Cushing Professor of Therapeutic Radiology and Professor of Pathology, Yale University; Gregory K. Friedman, MD, Professor, Department of Pediatrics Patient Care and Mosbacher Pediatrics Chair and Section Chief, Department of Pediatrics, The University of Texas MD Anderson Cancer Center \nModerator: Brenda Weigel, MD (Moderator), Vice President, Clinical Research Industry Engagement, St. Jude Children’s Research Hospital\n\nNovember | What Comes Next\n\n\nSpeakers / Date TBA\n\n\n\n\n
URL:https://www.cac2.org/cac2c-events/2026-curesearch-peds/
ORGANIZER;CN=CureSearch for Children's Cancer:MAILTO:
CATEGORIES:Community Event,Member Events,Virtual Event
LOCATION:4800 Hampden Ln, Bethesda, MD 20814
ATTACH;FMTTYPE=image/png:https://www.cac2.org/wp-content/uploads/2026/03/PEDS-and-CureSearch-logo-4.png
END:VEVENT
END:VCALENDAR